Pathogenetic bases of drug therapy of symptomatic benign prostatic hyperplasia with a-blockers

Автор: Kurbanova D.I.

Журнал: Экономика и социум @ekonomika-socium

Рубрика: Основной раздел

Статья в выпуске: 1-1 (92), 2022 года.

Бесплатный доступ

Currently, there is evidence of the objective effectiveness of the treatment of prostate adenoma.1-adrenoblockers. Drugs of this pharmacological group are used in the treatment of patients with mild or moderate symptoms of prostate adenoma, in addition, they can be prescribed during surgical practice, as well as to patients for whom surgical intervention is contraindicated or when the patient refuses surgical treatment. As a result, we can expect an increase in the number of potential patients suffering from prostatic hyperplasia. In this regard, the diagnosis and treatment of prostate adenoma is not only a serious medical, but also a serious social problem. In this article we will talk about solving the actual problem mentioned above.

Еще

A1-адреноблокаторы

Короткий адрес: https://sciup.org/140290917

IDR: 140290917

Статья научная